Labelled factor XIIIa substrates
US6653299B1 · kind B1 · utility
1Cited by
2References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 4, 1999 |
| Grant date | Nov 25, 2003 |
| Priority date | — |
| Expiry date | Oct 4, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2123/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A complex of a radiometal or paramagnetic metal ion with a metal chelating agent such as a diaminedioxime has attached thereto a substituent of formula —(Y)m—A—NHR, can function as a substrate for the fibrin-stabilizing Factor XIIIa. The complex is useful for the diagnosis or therapy of thrombosis, embolism, atherosclerosis, inflammation or cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.